57 related articles for article (PubMed ID: 19715837)
1. Results of hepatitis C virus treatment in patients on hemodialysis: data from published meta-analyses in 2008.
Casanovas Taltavull T; Baliellas Comellas C; Cruzado Garrit JM
Transplant Proc; 2009; 41(6):2082-4. PubMed ID: 19715837
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
Kaya S
Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis.
Casanovas-Taltavull T; Baliellas C; Llobet M; Cruzado JM; Castellote J; Casanova A; Niubó J; Valls C; Serrano T
Transplant Proc; 2007 Sep; 39(7):2125-7. PubMed ID: 17889113
[TBL] [Abstract][Full Text] [Related]
5. Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit.
Covic A; Maftei ID; Mardare NG; Ioniţă-Radu F; Totolici C; Tuţă L; Golea O; Covic M; Volovăţ C; Gusbeth-Tatomir P; Mircescu G
J Nephrol; 2006; 19(6):794-801. PubMed ID: 17173254
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis C in hemodialysis patients.
Berenguer M
Hepatology; 2008 Nov; 48(5):1690-9. PubMed ID: 18972442
[TBL] [Abstract][Full Text] [Related]
7. [Treatment in chronic renal failure].
Curciarello J; Fernández JL; Silva M
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
[No Abstract] [Full Text] [Related]
8. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
Teta D; Lüscher BL; Gonvers JJ; Francioli P; Phan O; Burnier M
Nephrol Dial Transplant; 2005 May; 20(5):991-3. PubMed ID: 15741205
[No Abstract] [Full Text] [Related]
9. Two consecutive episodes of acute hepatitis C with different genotypes in a hemodialysis patient responsive to PEG-interferon monotherapy.
Lederer S; Zachoval R; Hasholzner U; Schiffl H
Clin Nephrol; 2008 Apr; 69(4):313-6. PubMed ID: 18397710
[TBL] [Abstract][Full Text] [Related]
10. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis C infections in dialyzed patients].
Podlasin RB
Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients.
Chen J; Shi J; Xie WF; Zeng X; Lin Y
Int J Infect Dis; 2012 Oct; 16(10):e748-52. PubMed ID: 22836046
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials.
Chou R; Carson S; Chan BK
J Viral Hepat; 2008 Aug; 15(8):551-70. PubMed ID: 18482285
[TBL] [Abstract][Full Text] [Related]
14. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
[TBL] [Abstract][Full Text] [Related]
15. The response to pegylated interferon alpha 2a in haemodialysis patients with hepatitis C virus infection.
Akhan SC; Kalender B; Ruzgar M
Infection; 2008 Aug; 36(4):341-4. PubMed ID: 18629437
[TBL] [Abstract][Full Text] [Related]
16. Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.
Fabrizi F; Dixit V; Messa P; Martin P
J Viral Hepat; 2012 Nov; 19(11):784-91. PubMed ID: 23043385
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.
Huang CF; Yang JF; Dai CY; Huang JF; Hou NJ; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Chuang WL; Yu ML
J Infect Dis; 2010 Mar; 201(5):751-9. PubMed ID: 20102281
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia.
Zhang RF; Sun HQ; Huang Q; Wang JR; Zhang XX; Liu XN; Ma Q; Lu HZ
Haemophilia; 2010 May; 16(3):502-7. PubMed ID: 20028427
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience.
Maor Y; Schapiro JM; Bashari D; Lurie Y; Safadi R; Segol O; Paritsky M; Rachlis Z; Avidan B; Bar-Meir S; Martinowitz U
Haemophilia; 2008 Mar; 14(2):336-42. PubMed ID: 18205802
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection.
Chan TM; Ho SK; Tang CS; Tse KC; Lam MF; Lai KN; Yung S
Nephrology (Carlton); 2007 Feb; 12(1):11-7. PubMed ID: 17295655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
